The proliferation of substandard medicines represents a deeply concerning challenge facing the global healthcare landscape. These fraudulent products, often mimicking legitimate medications, pose a significant danger to consumer safety, undermining care effectiveness and potentially leading to severe harmful health consequences. Motivated by substa